Cancer Clinical Trials: Implications for Oncology Nurses

被引:5
|
作者
Portier, Wendy S. [1 ]
机构
[1] Portier & Associates LLC, New Orleans, LA USA
关键词
clinical trial; Food and Drug Administration; biomarker; informed consent; protocol; adverse event; clinical trial navigator;
D O I
10.1016/j.soncn.2020.150998
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: To explore the various types and phases of clinical trials, the regulatory oversight, drug approval process, and implications of clinical trials for the oncology nurse. Data Sources: Peer-reviewed journal articles, internet, book chapters, white papers. Conclusion: Oncology nurses' interactions with patients entered on clinical trial and communication with the clinical research team is crucial to the successful conduct of clinical trials. The oncology nurse must work in concert with the clinical research team to protect patient safety and to produce accurate information for protocol requirements that will be used to evaluate whether a drug becomes approved or not by the US Food and Drug Administration. Implications for Nursing Practice: Oncology nurses play a central role to the successful outcome of clinical research studies. Nurses must work in close collaboration with the clinical research teams for the successful completion and adherence of the clinical trial and to maintain the safety of the patient enrolled into clinical trial. (C) 2020 Elsevier Inc. All rights reserved.
引用
收藏
页数:6
相关论文
共 50 条
  • [1] Knowledge and Attitudes of Oncology Nurses towards Clinical Trials
    Bae, Jin Sil
    Kim, Jeong Nye
    ASIAN ONCOLOGY NURSING, 2023, 23 (01) : 29 - 37
  • [2] Perceptions of the ethical conduct of cancer trials by oncology nurses
    Beadle, G.
    Mengersen, K.
    Moynihan, S.
    Yates, P.
    EUROPEAN JOURNAL OF CANCER CARE, 2011, 20 (05) : 585 - 592
  • [3] Precision oncology for breast cancer through clinical trials
    Blucher, Aurora S.
    Mills, Gordon B.
    Tsang, Yiu Huen
    CLINICAL & EXPERIMENTAL METASTASIS, 2022, 39 (01) : 71 - 78
  • [4] Precision oncology: A new era of cancer clinical trials
    Renfro, Lindsay A.
    An, Ming-Wen
    Mandrekar, Sumithra J.
    CANCER LETTERS, 2017, 387 : 121 - 126
  • [5] Immunodynamics: a cancer immunotherapy trials network review of immune monitoring in immuno-oncology clinical trials
    Kohrt, Holbrook E.
    Tumeh, Paul C.
    Benson, Don
    Bhardwaj, Nina
    Brody, Joshua
    Formenti, Silvia
    Fox, Bernard A.
    Galon, Jerome
    June, Carl H.
    Kalos, Michael
    Kirsch, Ilan
    Kleen, Thomas
    Kroemer, Guido
    Lanier, Lewis
    Levy, Ron
    Lyerly, H. Kim
    Maecker, Holden
    Marabelle, Aurelien
    Melenhorst, Jos
    Miller, Jeffrey
    Melero, Ignacio
    Odunsi, Kunle
    Palucka, Karolina
    Peoples, George
    Ribas, Antoni
    Robins, Harlan
    Robinson, William
    Serafini, Tito
    Sondel, Paul
    Vivier, Eric
    Weber, Jeff
    Wolchok, Jedd
    Zitvogel, Laurence
    Disis, Mary L.
    Cheever, Martin A.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2016, 4
  • [6] Clinical trials in oncology
    Matos, Erika
    ONKOLOGIJA, 2018, 22 (01) : 38 - 41
  • [7] Clinical trials of interventional oncology
    Arai, Yasuaki
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2012, 17 (04) : 301 - 305
  • [8] Clinical trials in neurosurgical oncology
    Murphy, Meghan
    Parney, Ian F.
    JOURNAL OF NEURO-ONCOLOGY, 2014, 119 (03) : 569 - 576
  • [9] Clinical trials of interventional oncology
    Yasuaki Arai
    International Journal of Clinical Oncology, 2012, 17 : 301 - 305
  • [10] Clinical trials in neurosurgical oncology
    Meghan Murphy
    Ian F. Parney
    Journal of Neuro-Oncology, 2014, 119 : 569 - 576